Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery
Second Genome aims to identify a composite biomarker for the noninvasive diagnosis of nonalcoholic steatohepatitis patients with advanced fibrosis.
Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement
Persephone is developing precision immunotherapeutics using microbiome and other medical data from healthy individuals and cancer patients.
At ESHG, DeCode Genetics Highlights Integration of Proteomics, Genomics for Disease Research
DeCode has identified markers associated with osteoarthritis and autoimmune thyroid disease and is developing a calculator to predict five-year mortality risk.
Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer
The company will employ its Lattice platform to shepherd and translate genomic and other data toward the development of new early diagnostics and interventions.
Fluidigm Inks Comarketing Pacts With Ultivue, ImaBiotech
The separate comarketing agreements with Ultivue and ImaBiotech are related to Fluidigm's Imaging Mass Cytometry technology platform.